Product Code: ETC13345649 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Plasma Protein Therapeutic Market was valued at USD 5 Billion in 2024 and is expected to reach USD 7.27 Billion by 2031, growing at a compound annual growth rate of 5.60% during the forecast period (2025-2031).
The Global Plasma Protein Therapeutic Market is experiencing steady growth due to the increasing prevalence of rare diseases and chronic conditions requiring plasma-derived therapies. These therapies, such as immunoglobulins, albumin, and clotting factors, are vital for patients with immune deficiencies, neurological disorders, and hemophilia. The market is propelled by advancements in plasma fractionation techniques, growing awareness about the benefits of plasma protein therapies, and expanding healthcare infrastructure in emerging economies. However, regulatory challenges, high production costs, and supply chain disruptions can hinder market growth. Key players in the market include Grifols, CSL Behring, Takeda Pharmaceutical Company, and Octapharma. Ongoing research and development efforts to introduce innovative therapies and expand indications are expected to drive the market further.
The Global Plasma Protein Therapeutic Market is witnessing significant growth driven by increasing prevalence of chronic diseases, rising demand for immunoglobulin and albumin therapies, and advancements in biotechnology. Key trends include the growing adoption of plasma-derived therapies for rare diseases, expansion of plasma collection centers, and development of novel therapies utilizing plasma proteins. Opportunities in the market include the potential for personalized medicine approaches, increasing investment in research and development of new plasma protein therapeutics, and expanding market reach in emerging economies. Additionally, the COVID-19 pandemic has highlighted the importance of plasma-derived therapies in treating infectious diseases, further boosting demand in the market. Overall, the market is poised for continued growth and innovation in the coming years.
The Global Plasma Protein Therapeutic Market faces several challenges, including stringent regulatory requirements for plasma collection and processing, limited availability of plasma donors, and the potential risk of transmission of infectious diseases through plasma-derived products. Additionally, there is a growing concern over the affordability and accessibility of plasma protein therapies, as they can be expensive and may not be easily accessible to all patients in need. Competition among key market players and the need for continuous innovation to develop novel plasma-derived products further add to the challenges faced by the industry. Overall, navigating these challenges requires a careful balance of ensuring product safety, maintaining regulatory compliance, addressing supply chain issues, and meeting the healthcare needs of patients worldwide.
The Global Plasma Protein Therapeutic Market is primarily driven by the increasing prevalence of rare diseases and chronic conditions, which require treatment with plasma protein therapies. Additionally, the rising geriatric population worldwide, along with the growing awareness about the benefits of plasma protein therapies, is fueling market growth. Technological advancements in plasma fractionation processes and the development of novel therapies are also contributing factors. Moreover, the expanding applications of plasma protein therapeutics in various medical fields such as immunology, hematology, and neurology are driving market expansion. Furthermore, the favorable reimbursement policies for plasma protein therapies in many countries and the increasing healthcare expenditure are boosting market demand. These factors combined are expected to sustain the growth of the Global Plasma Protein Therapeutic Market in the foreseeable future.
Government policies play a crucial role in regulating the Global Plasma Protein Therapeutic Market to ensure product safety, efficacy, and availability. Key policies include stringent quality control standards for plasma collection, processing, and distribution, as well as regulations governing the production and marketing of plasma-derived therapies. Government agencies such as the FDA in the United States and the EMA in Europe oversee the approval and monitoring of plasma protein products to safeguard public health. Additionally, policies related to reimbursement, pricing, and market access influence the affordability and accessibility of plasma protein therapies for patients. Overall, government policies are essential in promoting innovation, ensuring product quality, and maintaining a sustainable market for plasma protein therapeutics.
The Global Plasma Protein Therapeutic Market is poised for significant growth in the coming years, driven by factors such as the increasing prevalence of chronic diseases, technological advancements in plasma fractionation techniques, and rising healthcare expenditure worldwide. The market is expected to see a steady rise in demand for plasma protein therapeutics, including immunoglobulins, albumin, and clotting factors, as these products are essential for treating a wide range of conditions such as immune deficiencies, neurological disorders, and hemophilia. Additionally, the expanding applications of plasma protein therapeutics in emerging markets and the growing awareness about the benefits of these treatments are likely to further propel market growth. However, challenges such as stringent regulatory requirements and the high cost of plasma-derived products could potentially hinder the market expansion to some extent.
In the Global Plasma Protein Therapeutic Market, Asia is experiencing significant growth due to increasing healthcare infrastructure and rising awareness about plasma protein therapies. North America remains a key market, driven by advanced healthcare facilities and high adoption rates of novel therapies. Europe is a mature market with a well-established regulatory framework, fostering steady growth in plasma protein therapeutics. The Middle East and Africa region is witnessing gradual growth, propelled by improving healthcare access and rising demand for plasma-derived products. Latin America is also showing promising growth potential, attributed to increasing healthcare expenditure and expanding pharmaceutical industry in the region. Overall, these regional insights highlight diverse opportunities for market players in the global plasma protein therapeutic market.
Global Plasma Protein Therapeutic Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Plasma Protein Therapeutic Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Plasma Protein Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Global Plasma Protein Therapeutic Market - Industry Life Cycle |
3.4 Global Plasma Protein Therapeutic Market - Porter's Five Forces |
3.5 Global Plasma Protein Therapeutic Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Plasma Protein Therapeutic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Plasma Protein Therapeutic Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.8 Global Plasma Protein Therapeutic Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Global Plasma Protein Therapeutic Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Plasma Protein Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Plasma Protein Therapeutic Market Trends |
6 Global Plasma Protein Therapeutic Market, 2021 - 2031 |
6.1 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Immunoglobulins, 2021 - 2031 |
6.1.3 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Albumin, 2021 - 2031 |
6.1.4 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Clotting Factors, 2021 - 2031 |
6.1.5 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Alpha-1 Antitrypsin, 2021 - 2031 |
6.1.6 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Source, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Human Plasma, 2021 - 2031 |
6.2.3 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Blood Plasma, 2021 - 2031 |
6.2.4 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Factor VIII, IX, 2021 - 2031 |
6.2.5 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Genetic Plasma, 2021 - 2031 |
6.2.6 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Plasma Protein Therapeutic Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.3.4 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Hemophilia Centers, 2021 - 2031 |
6.3.5 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Research Labs, 2021 - 2031 |
6.3.6 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Immune Deficiency Treatment, 2021 - 2031 |
6.4.3 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Liver & Kidney Disorders, 2021 - 2031 |
6.4.4 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Blood Disorder Management, 2021 - 2031 |
6.4.5 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Rare Diseases, 2021 - 2031 |
6.4.6 Global Plasma Protein Therapeutic Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Plasma Protein Therapeutic Market, Overview & Analysis |
7.1 North America Plasma Protein Therapeutic Market Revenues & Volume, 2021 - 2031 |
7.2 North America Plasma Protein Therapeutic Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Plasma Protein Therapeutic Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Plasma Protein Therapeutic Market, Revenues & Volume, By Source, 2021 - 2031 |
7.5 North America Plasma Protein Therapeutic Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America Plasma Protein Therapeutic Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Plasma Protein Therapeutic Market, Overview & Analysis |
8.1 Latin America (LATAM) Plasma Protein Therapeutic Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Plasma Protein Therapeutic Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Plasma Protein Therapeutic Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Plasma Protein Therapeutic Market, Revenues & Volume, By Source, 2021 - 2031 |
8.5 Latin America (LATAM) Plasma Protein Therapeutic Market, Revenues & Volume, By End User, 2021 - 2031 |
8.6 Latin America (LATAM) Plasma Protein Therapeutic Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Plasma Protein Therapeutic Market, Overview & Analysis |
9.1 Asia Plasma Protein Therapeutic Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Plasma Protein Therapeutic Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Plasma Protein Therapeutic Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Plasma Protein Therapeutic Market, Revenues & Volume, By Source, 2021 - 2031 |
9.5 Asia Plasma Protein Therapeutic Market, Revenues & Volume, By End User, 2021 - 2031 |
9.6 Asia Plasma Protein Therapeutic Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Plasma Protein Therapeutic Market, Overview & Analysis |
10.1 Africa Plasma Protein Therapeutic Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Plasma Protein Therapeutic Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Plasma Protein Therapeutic Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Plasma Protein Therapeutic Market, Revenues & Volume, By Source, 2021 - 2031 |
10.5 Africa Plasma Protein Therapeutic Market, Revenues & Volume, By End User, 2021 - 2031 |
10.6 Africa Plasma Protein Therapeutic Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Plasma Protein Therapeutic Market, Overview & Analysis |
11.1 Europe Plasma Protein Therapeutic Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Plasma Protein Therapeutic Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Plasma Protein Therapeutic Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Plasma Protein Therapeutic Market, Revenues & Volume, By Source, 2021 - 2031 |
11.5 Europe Plasma Protein Therapeutic Market, Revenues & Volume, By End User, 2021 - 2031 |
11.6 Europe Plasma Protein Therapeutic Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Plasma Protein Therapeutic Market, Overview & Analysis |
12.1 Middle East Plasma Protein Therapeutic Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Plasma Protein Therapeutic Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Plasma Protein Therapeutic Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Plasma Protein Therapeutic Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Plasma Protein Therapeutic Market, Revenues & Volume, By Source, 2021 - 2031 |
12.5 Middle East Plasma Protein Therapeutic Market, Revenues & Volume, By End User, 2021 - 2031 |
12.6 Middle East Plasma Protein Therapeutic Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Plasma Protein Therapeutic Market Key Performance Indicators |
14 Global Plasma Protein Therapeutic Market - Export/Import By Countries Assessment |
15 Global Plasma Protein Therapeutic Market - Opportunity Assessment |
15.1 Global Plasma Protein Therapeutic Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Plasma Protein Therapeutic Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Plasma Protein Therapeutic Market Opportunity Assessment, By Source, 2021 & 2031F |
15.4 Global Plasma Protein Therapeutic Market Opportunity Assessment, By End User, 2021 & 2031F |
15.5 Global Plasma Protein Therapeutic Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Plasma Protein Therapeutic Market - Competitive Landscape |
16.1 Global Plasma Protein Therapeutic Market Revenue Share, By Companies, 2024 |
16.2 Global Plasma Protein Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |